Skip to main content

Table 2 Age-adjusted odds ratios according to the Osteoprotegerin950 T/C genotype

From: A genetic polymorphism of the osteoprotegerin gene is associated with an increased risk of advanced prostate cancer

 

Age-adjusted odds ratio (95% CI, P) according to the Osteoprotegerin 950 T/C genotypea

Study group

CC

TC

TT

Prostate cancer against control

1.00

0.60 (0.345–1.032,0.065)

0.73 (0.418–1.302,0.294)

Tumor stageb

   

   Stage D against Stage A+B+C

1.00

1.72 (0.801–3.698, 0.164)

2.76 (1.289–5.938, 0.009)

   Stage C+D against Stage A+B

1.00

1.74 (0.937–3.253, 0.079)

2.03 (1.078–3.843, 0.028)

Tumor gradeb

   

   High against Low +Intermediate

1.00

1.27 (0.649–2.498, 0.482)

1.48 (0.750–2.947, 0.256)

  1. a These data were adjusted for age.
  2. b The tumor stage and grade systems are the same as those in Table 1.